The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients

Maja Smerdel, Karina Dahl Steffensen, Marianne Waldstrøm, Ivan Brandslund, Anders Jakobsen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2009
Publication statusPublished - 2009
EventInternational Meeting of the European Society of Gynaecological Oncology - Beograd, Serbia
Duration: 11. Oct 200914. Oct 2009
Conference number: 16

Conference

ConferenceInternational Meeting of the European Society of Gynaecological Oncology
Number16
Country/TerritorySerbia
CityBeograd
Period11/10/200914/10/2009

Bibliographical note

Citation: Journal of Gynecological Cancer, Volume 19, October 2009, Supplement 2
Oral presentation

Cite this